Deciphera Pharmaceuticals has received European Commission approval for Qinlock. The drug is used to treat adults with advanced gastrointestinal stromal tumors who have previously been treated with three or more kinase inhibitors.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept